Cargando…
The factors influencing the efficiency of drug-coated balloons
The drug-coated balloon (DCB) is an emerging percutaneous coronary intervention (PCI) device that delivers drugs to diseased vessels to decrease the rate of vascular stenosis. Recent clinical studies have demonstrated that DCBs tend to have both good safety and efficacy profiles, leading to extended...
Autores principales: | Cao, Zheng, Li, Jun, Fang, Zhao, Feierkaiti, Yushanjiang, Zheng, Xiaoxin, Jiang, Xuejun |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9602405/ https://www.ncbi.nlm.nih.gov/pubmed/36312265 http://dx.doi.org/10.3389/fcvm.2022.947776 |
Ejemplares similares
-
Duration of Dual Antiplatelet Therapy After Implantation of Drug-Coated Balloon
por: Zhang, Yuxuan, et al.
Publicado: (2021) -
Appropriate Surrogate Endpoint in Drug-Coated Balloon Trials for Coronary Artery Diseases
por: Lang, Xinyue, et al.
Publicado: (2022) -
Novel application of drug-coated balloons in coronary heart disease: A narrative review
por: Wang, Lijin, et al.
Publicado: (2023) -
Long-term outcomes of drug-coated balloons in patients with diffuse coronary lesions
por: Yang, Xinyue, et al.
Publicado: (2022) -
Case Report: Combination of Pressure Guidewire and Optical Coherence Tomography-Guided Drug-Coated Balloon Revascularization for Renal Artery Fibromuscular Dysplasia
por: Li, Yuxi, et al.
Publicado: (2022)